Business Description
Jamjoom Pharmaceuticals Factory Co
ISIN : SA15QGU1UNH6
Compare
Compare
Traded in other countries / regions
4015.Saudi IPO Date
2023-06-20Description
Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 57.17 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 3601.22 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 18.51 | |||||
| Beneish M-Score | -2.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11 | |||||
| 3-Year EBITDA Growth Rate | 6.7 | |||||
| 3-Year EPS without NRI Growth Rate | 10.9 | |||||
| 3-Year FCF Growth Rate | 36.5 | |||||
| 3-Year Book Growth Rate | 6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 17.69 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.88 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.07 | |||||
| 9-Day RSI | 47.75 | |||||
| 14-Day RSI | 47.87 | |||||
| 6-1 Month Momentum % | 5.48 | |||||
| 12-1 Month Momentum % | 37.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.34 | |||||
| Quick Ratio | 2.61 | |||||
| Cash Ratio | 0.36 | |||||
| Days Inventory | 168.29 | |||||
| Days Sales Outstanding | 159.78 | |||||
| Days Payable | 154.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.99 | |||||
| Dividend Payout Ratio | 0.6 | |||||
| Forward Dividend Yield % | 2.63 | |||||
| 5-Year Yield-on-Cost % | 1.97 | |||||
| Shareholder Yield % | 1.97 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.59 | |||||
| Operating Margin % | 29.54 | |||||
| Net Margin % | 27.56 | |||||
| FCF Margin % | 20.08 | |||||
| ROE % | 24.48 | |||||
| ROA % | 19.97 | |||||
| ROIC % | 26.29 | |||||
| ROC (Joel Greenblatt) % | 29.27 | |||||
| ROCE % | 24.75 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.2 | |||||
| Forward PE Ratio | 25.85 | |||||
| PE Ratio without NRI | 30.31 | |||||
| PS Ratio | 8.61 | |||||
| PB Ratio | 7.56 | |||||
| Price-to-Tangible-Book | 7.62 | |||||
| Price-to-Free-Cash-Flow | 42.86 | |||||
| Price-to-Operating-Cash-Flow | 35.18 | |||||
| EV-to-EBIT | 29.09 | |||||
| EV-to-EBITDA | 26.62 | |||||
| EV-to-Revenue | 8.52 | |||||
| EV-to-FCF | 42.87 | |||||
| Price-to-Graham-Number | 3.2 | |||||
| Price-to-Net-Current-Asset-Value | 15.51 | |||||
| Earnings Yield (Greenblatt) % | 3.43 | |||||
| FCF Yield % | 2.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jamjoom Pharmaceuticals Factory Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 1,267.733 | ||
| EPS (TTM) (ï·¼) | 5 | ||
| Beta | 0 | ||
| Volatility % | 35.02 | ||
| 14-Day RSI | 47.87 | ||
| 14-Day ATR (ï·¼) | 3.892992 | ||
| 20-Day SMA (ï·¼) | 156.37 | ||
| 12-1 Month Momentum % | 37.5 | ||
| 52-Week Range (ï·¼) | 112.8 - 202.4 | ||
| Shares Outstanding (Mil) | 70 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jamjoom Pharmaceuticals Factory Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jamjoom Pharmaceuticals Factory Co Stock Events
| Event | Date | Price(ï·¼) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jamjoom Pharmaceuticals Factory Co Frequently Asked Questions
What is Jamjoom Pharmaceuticals Factory Co(SAU:4015)'s stock price today?
The current price of SAU:4015 is ï·¼156.00. The 52 week high of SAU:4015 is ï·¼202.40 and 52 week low is ï·¼112.80.
When is next earnings date of Jamjoom Pharmaceuticals Factory Co(SAU:4015)?
The next earnings date of Jamjoom Pharmaceuticals Factory Co(SAU:4015) is .
Does Jamjoom Pharmaceuticals Factory Co(SAU:4015) pay dividends? If so, how much?
The Dividend Yield %  of Jamjoom Pharmaceuticals Factory Co(SAU:4015) is 1.99% (As of Today), Highest Dividend Payout Ratio of Jamjoom Pharmaceuticals Factory Co(SAU:4015) was 0.6. The lowest was 0.24. And the median was 0.24. The  Forward Dividend Yield % of Jamjoom Pharmaceuticals Factory Co(SAU:4015) is 2.63%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers